Core Viewpoint - The article discusses three ultra-high-yield dividend stocks that investors should consider, highlighting their strong performance and growth potential in the current market environment. Group 1: Ares Capital - Ares Capital has a forward yield of 9.3% and has maintained stable or growing payouts for 15 consecutive years [3][5] - The company has the highest regular dividend growth over the last 10 years among externally managed business development companies with a market cap over $700 million [3] - Ares Capital primarily provides capital to middle-market businesses, representing a $3 trillion opportunity, with an additional $2.4 trillion from companies with revenues over $1 billion [4] - The company is well-positioned to capture market share, being the largest publicly traded business development company with a strong balance sheet and deep industry relationships [5] - Concerns regarding the CEO transition are mitigated by the new CEO's extensive experience within the company and industry [6] Group 2: Enterprise Products Partners - Enterprise Products Partners offers a forward yield of 6.9% and has increased its distribution for 26 consecutive years [7] - The company has demonstrated resilience in its cash flows during economic downturns, including the Great Recession and the COVID-19 pandemic [8] - Global demand for liquid hydrocarbons is expected to grow, with the U.S. maintaining a competitive advantage due to low production costs, positively impacting Enterprise's growth prospects [9] Group 3: Verizon Communications - Verizon Communications has a forward dividend yield of 6.3% and has increased its payouts for 18 straight years [10] - Despite a declining stock market, Verizon's share price has risen due to limited exposure to tariffs and strong business performance [11][12] - The company is expanding its offerings through the acquisition of Frontier Communications, expected to close in Q1 2026, which will enhance its products and services for consumers and small businesses [13]

we discuss ideas like this as they happen in more detail. All active investors are welcome to join on a free trial and ask any question in our chat room full of sophisticated traders and investors.We continue with our effort to catch the BDC bottom with a pair trade. Until recently, many BDCs were trading at overvalued levels. We discussed this in previous articles, like MAIN, PBDC, CGBD and many others. However, the situation has changed -Denislav leads the investing group Trade With Beta , features of the ...

Financial Data and Key Metrics Changes - The company generated net investment income (NII) of $0.27 per share, consistent with the previous quarter but down from $0.38 per share in the same quarter last year [26] - The net asset value (NAV) decreased to $7.57 per share from $8.43 at the end of the previous quarter and $9.64 a year ago, primarily due to fair value adjustments and distributions [27] - Investment income for the first quarter was $25 million, slightly down from $26 million in the prior year period, attributed to lower interest and fee income [24] Business Line Data and Key Metrics Changes - The portfolio at the end of the first quarter stood at $690 million, with new debt investments totaling $100 million and equity investments of $2 million [11] - The debt portfolio yield was 15% for the quarter, compared to 15.6% in the same quarter last year, while onboarding yields were 13%, up from 12.6% in the previous quarter [24][12] - The company funded nine debt investments during the quarter, with a significant portion directed towards life science and technology sectors [11] Market Data and Key Metrics Changes - Approximately $92 billion was invested in VC-backed companies in the first quarter, marking a 19% increase from the previous quarter, driven largely by large AI deals [17] - The exit market for VC-backed tech and life science companies remains nearly shut due to tariff-related uncertainties, impacting investor sentiment [18] - The S&P Biotech Select Industry Index is down 14% year over year, reflecting cooling investor sentiment in the life sciences market [18] Company Strategy and Development Direction - The company aims to grow its portfolio while maintaining a focus on high-quality investments, particularly in the tech and life science sectors [10] - The management remains selective in originating loans due to the current macroeconomic environment, with a commitment to optimizing returns from stressed investments [15] - The partnership with Monroe Capital is expected to enhance capital access and operational support, aiding in portfolio growth [9] Management's Comments on Operating Environment and Future Outlook - The management expressed guarded optimism for 2025, despite macroeconomic headwinds impacting recovery from stressed assets [6] - The company anticipates that the venture debt market will remain active, providing opportunities for investment despite current challenges [10] - Management highlighted the importance of maintaining strong liquidity and a robust balance sheet to navigate the current environment [23] Other Important Information - The company declared regular monthly distributions of $0.11 per share through September 2025, supported by undistributed spillover income of $1 per share [7][26] - The company has a committed backlog of $236 million, providing a solid base for future portfolio growth [8] Q&A Session Summary Question: How is the company managing spillover earnings in the current uncertain environment? - The company plans to continue growing distributions through 2025 and will manage spillover earnings quarterly, with confidence in covering distributions over time [32][34] Question: What is the quality of deals currently being pursued? - The company is seeing a higher bar for transaction selection, focusing on companies with strong operational performance and quality VC backing [36][37] Question: Will the company raise leverage ratios to grow the portfolio? - The target leverage ratio is around 1.2x to 1.3x, with the current ratio at 1.29x, indicating a cautious approach to leverage [41] Question: Is there any discussion about cutting the base management fee? - The company’s base management fee is competitive with industry standards, and it is reviewed regularly [43] Question: How does the company plan to address the frozen market conditions? - The company is focusing on generating yield through higher returns from existing portfolio companies rather than relying on warrant expectations [55][52] Question: What is the impact of tariffs on the portfolio? - The primary impact of tariffs is the uncertainty they create, affecting market transactions rather than direct exposure to specific tariffs [63] Question: Has the partnership with Monroe Capital provided additional resources? - The partnership is expected to enhance operational support and focus on stabilizing and growing the business [66]

NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Chicago Atlantic BDC, Inc. (the “Company”) (NASDAQ: LIEN), a specialty finance company that has elected to be regulated as a business development company, today announced details for the release of its financial results for the first quarter ended March 31, 2025. The Company plans to release its financial results for the first quarter ended March 31, 2025 before the market opens on Wednesday, May 14, 2025, and host a conference call and live audio webcast, both o ...

Ares Capital (ARCC) Q1 2025 Earnings Call April 29, 2025 05:38 PM ET Speaker0 Good afternoon. Welcome to Ares Capital Corporation's First Quarter Ended 03/31/2025 Earnings Conference Call. At this time, all participants are in a listen only mode. As a reminder, this conference is at 09:20 twenty five. I will now turn the call over to Mr. John Sylmar, a partner on Ares Public Markets Investor Relations team. Speaker1 Thank you. And let me start with some important reminders. Comments during the course of thi ...

Financial Data and Key Metrics Changes - The company reported GAAP net income per share of $0.60 for Q1 2025, down from $0.76 in Q1 2024 and $0.55 in the previous quarter [19] - Core earnings per share were $0.50, compared to $0.59 a year ago and $0.55 in the prior quarter, primarily due to a decline in portfolio yields [19][20] - The total portfolio at fair value increased to $27.1 billion from $26.7 billion in the previous quarter and $23.1 billion a year ago [21] Business Line Data and Key Metrics Changes - The company committed $3.5 billion in gross commitments during the first quarter, a 54% increase compared to the same period last year [9][10] - The weighted average yield on debt and other income-producing securities at amortized cost was 11.1% at the end of Q4 2024, down to 10.1% by the end of Q1 2025 [20] - The portfolio companies reported a 12% weighted average LTM EBITDA growth, up from 11% in the prior quarter [28] Market Data and Key Metrics Changes - New transaction activity in the liquid loan market dropped significantly as banks became more cautious, leading to increased volatility and widening spreads in secondary loan markets [10][11] - The direct lending market remained stable, with certain transactions shifting from the syndicated loan market to private credit solutions [11] Company Strategy and Development Direction - The company aims to leverage its strong liquidity and conservative balance sheet leverage to capitalize on potential investment opportunities in a potentially improving spread environment [10][14] - The focus remains on domestic service-oriented businesses, which are believed to be more insulated from the impacts of higher tariffs [15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate future market conditions, citing a seasoned investment team and strong relationships in the market [12][13] - The company declared a quarterly dividend of $0.48 per share, marking the 63rd consecutive quarter of stable or increasing dividends [17][24] Other Important Information - The company has nearly $6.8 billion in total available liquidity, positioning it well for future investments [22] - The non-accrual rate at cost ended the quarter at 1.5%, down from the previous quarter, indicating strong portfolio health [29] Q&A Session Summary Question: Will private credit provide similar or lower pricing than banks? - Management noted that spreads have already started to widen, indicating a shift in the market dynamics [35][36] Question: What is the exposure to tariffs for portfolio companies? - The company conducted a thorough analysis and found a mid-single-digit exposure to companies importing from high-tariff countries, emphasizing that this is an exposure analysis, not an impact analysis [39][41] Question: How does the company plan to manage earnings against rising costs of liabilities? - Management highlighted the ability to adjust leverage and utilize spillover income to manage costs effectively [50][54] Question: Is there a trend in portfolio stress or sectors experiencing issues? - Management indicated that there are no significant trends observed in portfolio stress at this time [102] Question: What is the outlook for new investment opportunities? - Management expressed optimism about the potential for larger deals in the private credit market, indicating a readiness to pivot as market conditions change [84][85]

NEW YORK, April 28, 2025 /PRNewswire/ -- WhiteHorse Finance, Inc. ("WhiteHorse Finance" or the "Company") (Nasdaq: WHF) today announced that it will release its first quarter financial results for the period ended March 31, 2025 on Monday, May 12, 2025. The Company will discuss its financial results on a conference call on Tuesday, May 13, 2025 at 4:30 p.m. ET.To access the teleconference, please dial 800-267-6316 (domestic) or +1 203-518-9783 (international) approximately 10 minutes before the teleconferen ...

DALLAS, April 28, 2025 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (“Capital Southwest”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, is pleased to announce that its Board of Directors has declared a regular dividend of $0.58 per share and a supplemental dividend of $0.06 per share for the quarter ending June 30, 2025. The Company’s dividends will be payable as fol ...

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or ...

Core Viewpoint - Oxford Square Capital Corp. reported its financial results for the quarter ended March 31, 2025, highlighting a decrease in net asset value and net losses from operations compared to the previous quarter [1]. Financial Performance - Net asset value (NAV) per share decreased to $2.09 as of March 31, 2025, down from $2.30 on December 31, 2024 [1]. - Net investment income (NII) for the quarter was approximately $6.1 million, or $0.09 per share, compared to $6.0 million, or $0.09 per share, for the previous quarter [1]. - Total investment income remained stable at approximately $10.2 million for the quarter, similar to the previous quarter [1]. - Total expenses for the quarter were approximately $4.1 million, a slight decrease from $4.2 million in the previous quarter [1]. Investment Income Breakdown - Investment income for the quarter included $5.5 million from debt investments, $4.0 million from CLO equity investments, and $0.7 million from other income [1]. - The weighted average yield of debt investments was 14.3%, down from 15.8% as of December 31, 2024 [1]. - The weighted average effective yield of CLO equity investments increased to 9.0% from 8.8% in the previous quarter [1]. - The cash distribution yield of cash income-producing CLO equity investments was 16.0%, slightly down from 16.2% [1]. Operational Metrics - The company recorded a net decrease in net assets resulting from operations of approximately $8.1 million, which included NII of $6.1 million, net realized losses of $12.2 million, and net unrealized depreciation of $2.1 million [1]. - Investment activity included purchases of approximately $16.0 million, sales of approximately $10.7 million, and repayments of approximately $8.7 million during the quarter [1]. - The weighted average credit rating was 2.2 based on total fair value, down from 2.3 as of December 31, 2024 [1]. Shareholder Distributions - The Board of Directors declared distributions of $0.035 per share for July, August, and September 2025 [1]. - The company issued approximately 1.3 million shares of common stock, resulting in net proceeds of approximately $3.5 million [1]. Assets and Liabilities - Total assets as of March 31, 2025, were approximately $285.5 million, down from $299.7 million as of December 31, 2024 [5]. - Total liabilities were approximately $136.6 million, compared to $139.1 million in the previous quarter [5]. - Net assets totaled approximately $148.9 million, down from $160.7 million [5].